Promoters hold 66.0% of BALAXI PHARMACEUTICALS LIMITED (BALAXI). FIIs hold 0.0%, mutual funds 0.0% and other DIIs 2.6%. No promoter pledge is reported. Quarterly shareholding, quarter ended Jun 26.
Folio counts aren't part of the shareholding pattern we ingest today — they arrive with a later filing parse.
| Holder | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Apr 24 | Mar 24 | Feb 24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 66.0% | 66.0% | 66.0% | 66.0% | 66.0% | 66.0% | 66.0% | 66.0% | 66.0% | 66.4% | 66.9% | 67.8% |
| FII | 0.0% | 0.0% | 1.7% | 3.5% | 8.9% | 16.0% | 16.5% | 16.5% | 16.9% | 17.1% | 17.2% | 17.4% |
| MF | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Other DII | 2.6% | 2.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Retail & others | 31.4% | 31.4% | 32.2% | 30.5% | 25.1% | 18.0% | 17.5% | 17.5% | 17.1% | 16.5% | 15.9% | 14.7% |
No bulk or block deals disclosed for this stock in the last 90 days.
Bulk deals are uncommon for large caps — a single client has to trade over 0.5% of the company's shares in one day. Most weeks, none happen.
No PIT or SAST disclosures on record for this stock in the last 12 months.
That is the usual state — promoters, directors and holders above 5% file only when they trade or pledge; a new filing appears here within a day of reaching the exchange.
Promoters hold 65.99% as of Jun 26; institutional ownership was broadly unchanged this quarter.
Quarterly shareholding patternas of Jun 26
